Value through Innovation27 July 2016

What is a lay summary?

To view this video in other translations click on the language below:
Chinese (simplified)
Chinese (traditional)
French
German
Italian
Japanese
Portuguese (Brazilian)
Spanish

Clinical Study Results

  • BI 705564 - Lupus Erythematosus, Systemic
    Clinical Study Number 1408-0004
    Study Indication Lupus Erythematosus, Systemic
    Product BI 705564
    Generic Name BI 705564
    Lab Code BI 705564
    Clinical Phase Ib
    Study Title

    A phase Ib, multicentre, randomised, double-blind, placebo controlled, 8 week crossover study to assess the safety, tolerability and pharmacokinetics of orally administered BI 705564 in patients with systemic lupus erythematosus

    Study Document
    Trial statement 1408-0004 english